Literature DB >> 16890972

15-deoxy-Delta12,14-prostaglandin J2 induces renal epithelial cell death through NF-kappaB-dependent and MAPK-independent mechanism.

Dae Sik Kang1, Chae Hwa Kwon, Ji Yeon Park, Jae Ho Kim, Jae Suk Woo, Jin Sup Jung, Yong Keun Kim.   

Abstract

The peroxisome proliferator-activated receptor-gamma (PPARgamma) ligand 15d-PGJ2 induces cell death in renal proximal tubular cells. However, the underlying molecular mechanism(s) remains unidentified. The present study was undertaken to examine the roles of reactive oxygen species (ROS), mitogen-activated protein kinase, and NF-kappaB in opossum kidney (OK) cell death induced by 15d-PGJ2. Treatment of OK cells with 15d-PGJ2 resulted in a concentration- and time-dependent cell death, which was largely attributed to apoptosis. 15d-PGJ2 increased ROS production and the effect was inhibited by catalase and N-acetylcysteine. The 15d-PGJ2-induced cell death was also prevented by these antioxidants, suggesting that the cell death was associated with ROS generation. The PPARgamma antagonist GW9662 did not prevent the 15d-PGJ2-induced cell death. 15d-PGJ2 caused a transient activation of extracellular signal-regulated kinase (ERK). However, inhibitors (PD98059 and U0126) of MEK, an ERK upstream kinase, did not alter the 15d-PGJ2-induced cell death. Transfection with constitutively active MEK and dominant-negative MEK had no effect on the cell death. 15d-PGJ2 inhibited the NF-kappaB transcriptional activity, which was accompanied by an inhibition of nuclear translocation of the NF-kappaB subunit p65 and impairment in DNA binding. Inhibition of NF-kappaB with a NF-kappaB specific inhibitor pyrrolidinecarbodithioate and transfection with IkappaBalpha (S32A/36A) caused cell death. These results suggest that the 5d-PGJ2-induced OK cell death was associated with ROS production and NF-kappaB inhibition, but not with MAPK activation.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16890972     DOI: 10.1016/j.taap.2006.06.008

Source DB:  PubMed          Journal:  Toxicol Appl Pharmacol        ISSN: 0041-008X            Impact factor:   4.219


  5 in total

1.  Sustained neuroprotection from a single intravitreal injection of PGJ2 in a rodent model of anterior ischemic optic neuropathy.

Authors:  Valerie Touitou; Mary A Johnson; Yan Guo; Neil R Miller; Steven L Bernstein
Journal:  Invest Ophthalmol Vis Sci       Date:  2013-11-11       Impact factor: 4.799

Review 2.  PPARγ signaling and emerging opportunities for improved therapeutics.

Authors:  Shuibang Wang; Edward J Dougherty; Robert L Danner
Journal:  Pharmacol Res       Date:  2016-06-04       Impact factor: 7.658

3.  Cytotoxicity of 15-deoxy-Δ(12,14)-prostaglandin J(2) through PPARγ-independent pathway and the involvement of the JNK and Akt pathway in renal cell carcinoma.

Authors:  Megumi Fujita; Chiaki Tohji; Yoko Honda; Yasuhiro Yamamoto; Tsutomu Nakamura; Tatsurou Yagami; Motohiro Yamamori; Noboru Okamura
Journal:  Int J Med Sci       Date:  2012-09-04       Impact factor: 3.738

4.  Cytotoxic effects of 15d-PGJ2 against osteosarcoma through ROS-mediated AKT and cell cycle inhibition.

Authors:  Chueh-Chuan Yen; Chung-Der Hsiao; Wei-Ming Chen; Yao-Shan Wen; Yung-Chan Lin; Ting-Wei Chang; Fang-Yi Yao; Shih-Chieh Hung; Jir-You Wang; Jen-Hwey Chiu; Hsei-Wei Wang; Chi-Hung Lin; Tain-Hsiung Chen; Paul Chih-Hsueh Chen; Chien-Lin Liu; Cheng-Hwai Tzeng; Jonathan A Fletcher
Journal:  Oncotarget       Date:  2014-02-15

5.  15-Deoxy-Δ12,14-prostaglandin J2 Exerts Antioxidant Effects While Exacerbating Inflammation in Mice Subjected to Ureteral Obstruction.

Authors:  Line Nilsson; Fredrik Palm; Rikke Nørregaard
Journal:  Mediators Inflamm       Date:  2017-04-19       Impact factor: 4.711

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.